152 related articles for article (PubMed ID: 32300959)
1. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Sugiyama M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):886-893. PubMed ID: 32300959
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.
Schleicher S; Grote S; Malenke E; Chan KC; Schaller M; Fehrenbacher B; Riester R; Kluba T; Frauenfeld L; Boesmueller H; Göhring G; Schlegelberger B; Handgretinger R; Kopp HG; Traub F; Boehme KA
Cells; 2020 Dec; 9(12):. PubMed ID: 33322555
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
5. Functional impact and targetability of
Choo F; Odintsov I; Nusser K; Nicholson KS; Davis L; Corless CL; Stork L; Somwar R; Ladanyi M; Davis JL; Davare MA
Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 35012940
[TBL] [Abstract][Full Text] [Related]
6. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Ono T; Toki S; Kobayashi E; Arakawa A; Sugiyama M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
[TBL] [Abstract][Full Text] [Related]
8. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Rekhi B; Upadhyay P; Ramteke MP; Dutt A
Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
10. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sin Y; Ono T; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1911-1918. PubMed ID: 34383271
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.
Chen S; Rudzinski ER; Arnold MA
Surg Pathol Clin; 2020 Dec; 13(4):729-738. PubMed ID: 33183730
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity:
Gorunova L; Bjerkehagen B; Micci F; Heim S; Panagopoulos I
Cancer Genomics Proteomics; 2020; 17(5):563-569. PubMed ID: 32859634
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Nakagawa M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):894-903. PubMed ID: 32356243
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Nakatani F; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):400-407. PubMed ID: 34775549
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):246-253. PubMed ID: 32870449
[TBL] [Abstract][Full Text] [Related]
17. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Iwata S; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
